We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo ADLM 2026 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Molecular Diagnostics

Image: The findings provide the first evidence that pre-treatment epigenetic signals in cfDNA can distinguish semaglutide responders from non-responders, with important implications for the future of precision medicine in GLP-1 therapy (Photo credit: Adobe Stock)

Blood-Based Epigenetic Test Predicts GLP-1 Response and Tracks Treatment Effects

A new blood-based cfDNA methylation test and AI platform predicts semaglutide responders pre-treatment. More...
07 May 2026
Image: The findings support tumor genomic testing in pituitary carcinomas and aggressive pituitary adenomas, to guide consideration of immunotherapy as a potential first-line option (photo courtesy of Adobe Stock)

Tumor Genomic Testing Guides Immunotherapy Selection in Pituitary Tumors

DNA testing for mismatch repair alterations guides immunotherapy, enabling complete responses in aggressive pituitary tumors. More...
05 May 2026
Image: Usability assessment (Yerlikaya S, Chirwa M, Ajide B, et al.; New England Journal of Medicine (2026). DOI: 10.1056/NEJMoa2509761)

Rapid Tongue Swab Molecular Test Detects Pulmonary Tuberculosis at Point of Care

A new tongue swab-based molecular test enables <35 min TB detection with 80% sensitivity and 99.5% specificity. More...
05 May 2026
Image: The minimally invasive, cost-effective liquid biopsy offers an accessible alternative to tissue biopsy for tailoring breast cancer treatment strategies (photo credit: 123RF)

Liquid Biopsy Predicts Immunotherapy Response in Breast Cancer

A new liquid biopsy transcriptome assay predicts pembrolizumab response and neoadjuvant outcomes in HER2-negative breast cancer. More...
05 May 2026
Image: Stuart Ibsen, Ph.D., led the team that developed a new technique using an electronic jolt and nanoparticles to reveal the telltale signal of an insidious form of cancer (Photo courtesy of OHSU/Christine Torres Hicks)

New Blood Test Distinguishes Pancreatic Cancer From Benign Disease

A blood test using tumor-shed nanoparticles differentiates pancreatic cancer from benign disease with 97% accuracy. More...
04 May 2026
Image: Unity Confirm is a circulating fetal cell–based confirmation test designed for use following a high‑risk Unity Aneuploidy Screen result (Photo courtesy of BillionToOne)

Noninvasive Test Confirms High-Risk Prenatal Screening Results from Blood

A new fetal cell–based test confirms high‑risk NIPT for common aneuploidies and 22q11.2 microdeletion. More...
04 May 2026
Image: A machine learning tool, T1GRS, accurately predicts genetic risk of type 1 diabetes in children and adults (Photo courtesy of Adobe Stock)

Machine-Learning Genetic Risk Score Improves Early Prediction of Type 1 Diabetes

An AI-derived genetic risk score improves early type 1 diabetes prediction across populations, enabling broader screening. More...
04 May 2026
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
New
Platelet Function Analyzer
PL-12


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.